ArticleFrontiers in immunology2024

Dynamics trajectory of patient-reported quality of life and its associated risk factors among hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a prospective cohort study.

Xue-Mei You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.